These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 675000)

  • 41. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Anti-D prophylaxis after abortions and interruptions].
    Maas DH
    Fortschr Med; 1979 Jan; 97(4):148-52. PubMed ID: 217809
    [TBL] [Abstract][Full Text] [Related]  

  • 43. INFLUENCE OF FOETAL A AND B BLOOD-GROUP SUBSTANCES ON THE IMMUNIZATION OF PREGNANT WOMEN.
    HOSTRUP H
    Vox Sang; 1964; 9():301-14. PubMed ID: 14170900
    [No Abstract]   [Full Text] [Related]  

  • 44. Rho (D) immune prophylaxis. A double-blind cooperative study.
    White CA; Visscher RD; Visscher HC; Wade ME
    Obstet Gynecol; 1970 Sep; 36(3):341-6. PubMed ID: 4988961
    [No Abstract]   [Full Text] [Related]  

  • 45. Significance of positive direct anti-globulin test for cord blood--in administration of anti-d immunoglobulin for postpartum immunoprophylaxis.
    Nakamura Y; Sada I; Tanaka S; Nomura Y; Shinagawa S
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Apr; 36(4):623-5. PubMed ID: 6425437
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiple differences in red cell antigens and isoimmunization.
    Stern K
    Transfusion; 1975; 15(3):179-94. PubMed ID: 805483
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV; Beck ML
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract]   [Full Text] [Related]  

  • 49. The groupamatic system for routine immunohematology.
    Garretta M; Gener J; Muller A; Matte C; Moullec J
    Transfusion; 1975; 15(5):422-31. PubMed ID: 812219
    [TBL] [Abstract][Full Text] [Related]  

  • 50. AMORBUS HAEMOLYTICUS NEONATORUM DUE TO RH IMMUNIZATION. A CLINICAL AND BLOOD GROUP SEROLOGICAL STUDY.
    Nilsson BA
    Acta Obstet Gynecol Scand; 1965; 44(S2):7-81. PubMed ID: 14327987
    [No Abstract]   [Full Text] [Related]  

  • 51. The management of rhesus iso-immunization.
    Walker W
    J Obstet Gynaecol Br Commonw; 1968 Dec; 75(12):1207-8. PubMed ID: 4973666
    [No Abstract]   [Full Text] [Related]  

  • 52. Non-rhesus (D) blood group isoimmunization in obstetrics.
    Beal RW
    Clin Obstet Gynaecol; 1979 Dec; 6(3):493-508. PubMed ID: 116796
    [No Abstract]   [Full Text] [Related]  

  • 53. [Icterus gravis and exchange transfusion].
    Tulzer W; Griebler T
    Wien Med Wochenschr; 1967 Apr; 117(13):334-7. PubMed ID: 4968441
    [No Abstract]   [Full Text] [Related]  

  • 54. The assessment of fetal-maternal hemorrhage by an enzyme-linked antiglobulin test for Rh immune globulin recipients.
    Ness PM
    Am J Obstet Gynecol; 1982 Aug; 143(7):788-92. PubMed ID: 6179419
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transplacental fetal-maternal hemorrhage: a review.
    Skaggs R
    J Am Osteopath Assoc; 1976 Mar; 75(7):658-65. PubMed ID: 56347
    [No Abstract]   [Full Text] [Related]  

  • 56. Diagnostic laboratory technologies for the fetus and neonate with isoimmunization.
    Geaghan SM
    Semin Perinatol; 2011 Jun; 35(3):148-54. PubMed ID: 21641488
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Prevalence of immunohematologic tests at birth and the incidence of hemolytic disease in the newborn].
    Cianciarullo MA; Ceccon ME; Vaz Fv
    Rev Assoc Med Bras (1992); 2003; 49(1):45-53. PubMed ID: 12724812
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [On the problem of ABO-incompatibility].
    Rudelić I
    Med Klin; 1967 Nov; 62(47):1825-7. PubMed ID: 5588927
    [No Abstract]   [Full Text] [Related]  

  • 59. [Analysis of Screening Results in 501 Newborns with Hemolytic Disease].
    Ma X; Chen FZ; Hong Q
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):192-196. PubMed ID: 30738469
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Maternal antibodies against fetal blood group antigens A or B: lytic activity of IgG subclasses in monocyte-driven cytotoxicity and correlation with ABO haemolytic disease of the newborn.
    Brouwers HA; Overbeeke MA; Ouwehand WH; Keuning K; van Ertbruggen I; van Leeuwen EF; Stoop JW; Engelfriet CP
    Br J Haematol; 1988 Dec; 70(4):465-9. PubMed ID: 3219297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.